146 related articles for article (PubMed ID: 24749660)
1. Uricaemia and ejection fraction in elderly heart failure outpatients.
Borghi C; Cosentino ER; Rinaldi ER; Cicero AF
Eur J Clin Invest; 2014 Jun; 44(6):573-8. PubMed ID: 24749660
[TBL] [Abstract][Full Text] [Related]
2. Kidney Function, Nutritional Status, and the Left Ventricle Dysfunction Are Associated with Serum Uric Acid Levels in Patients with Heart Failure with Reduced Ejection Fraction.
Owczarek AJ; Choręza P; Arabzada H; Chudek J; Wojnicz R
Ann Clin Lab Sci; 2018 Sep; 48(5):608-613. PubMed ID: 30373865
[TBL] [Abstract][Full Text] [Related]
3. Is Serum Uric Acid Independently Associated With Left Ventricular Mass Index, Ejection Fraction, and B-Type Natriuretic Peptide Among Female and Male Cardiac Patients?
Yamauchi Y; Fujita SI; Shibata K; Morita H; Ito T; Sohmiya K; Hoshiga M; Ishizaka N
Int Heart J; 2017 Aug; 58(4):562-569. PubMed ID: 28701671
[TBL] [Abstract][Full Text] [Related]
4. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure.
Tasevska-Dinevska G; Kennedy LM; Cline-Iwarson A; Cline C; Erhardt L; Willenheimer R
Int J Cardiol; 2011 Jun; 149(3):364-71. PubMed ID: 20202706
[TBL] [Abstract][Full Text] [Related]
6. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
7. Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).
Vaduganathan M; Greene SJ; Ambrosy AP; Mentz RJ; Subacius HP; Chioncel O; Maggioni AP; Swedberg K; Zannad F; Konstam MA; Senni M; Givertz MM; Butler J; Gheorghiade M;
Am J Cardiol; 2014 Dec; 114(11):1713-21. PubMed ID: 25312638
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid and outcome in hospitalized elderly patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes.
Yan W; Tang HY; Yang YQ; He KL
BMC Cardiovasc Disord; 2023 Nov; 23(1):589. PubMed ID: 38036986
[TBL] [Abstract][Full Text] [Related]
9. Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
Liu C; Zhao Q; Zhen Y; Gao Y; Tian L; Wang L; Ji L; Liu G; Ji Z; Liu K
Can J Cardiol; 2013 Sep; 29(9):1048-54. PubMed ID: 23395281
[TBL] [Abstract][Full Text] [Related]
10. Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients.
Mulè G; Riccobene R; Castiglia A; D'Ignoto F; Ajello E; Geraci G; Guarino L; Nardi E; Vaccaro F; Cerasola G; Cottone S
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):744-50. PubMed ID: 24675008
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
[TBL] [Abstract][Full Text] [Related]
12. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Kanbay M; Pitt B; Dickstein K; Zannad F; Rossignol P;
Eur J Heart Fail; 2015 Nov; 17(11):1144-51. PubMed ID: 26424212
[TBL] [Abstract][Full Text] [Related]
13. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.
Akiyama E; Sugiyama S; Matsuzawa Y; Konishi M; Suzuki H; Nozaki T; Ohba K; Matsubara J; Maeda H; Horibata Y; Sakamoto K; Sugamura K; Yamamuro M; Sumida H; Kaikita K; Iwashita S; Matsui K; Kimura K; Umemura S; Ogawa H
J Am Coll Cardiol; 2012 Oct; 60(18):1778-86. PubMed ID: 23040568
[TBL] [Abstract][Full Text] [Related]
14. Serum uric acid is associated with cardiac diastolic dysfunction among women with preserved ejection fraction.
Nogi S; Fujita S; Okamoto Y; Kizawa S; Morita H; Ito T; Sakane K; Sohmiya K; Hoshiga M; Ishizaka N
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H986-94. PubMed ID: 26209055
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry.
Baldasseroni S; Urso R; Maggioni AP; Orso F; Fabbri G; Marchionni N; Tavazzi L;
Nutr Metab Cardiovasc Dis; 2012 May; 22(5):442-8. PubMed ID: 21193292
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.
Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G
Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure.
Stubnova V; Os I; Høieggen A; Solbu MD; Grundtvig M; Westheim AS; Atar D; Waldum-Grevbo B
BMC Cardiovasc Disord; 2019 Jan; 19(1):4. PubMed ID: 30611196
[TBL] [Abstract][Full Text] [Related]
18. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
[TBL] [Abstract][Full Text] [Related]
19. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
